Warning Letter Roundup: FDA Warns Drugmakers for Variety of Issues

Drug GMP Report
The FDA slapped three drug manufacturers — including two Chinese firms — with warning letters after the agency’s inspections revealed a wide range of issues at the facilities, such as adulterated products and the lack of a quality unit.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00